| Autor: |
Ballif, A., Gerber, S., Carrez, L., Audry, M., Sadeghipour, F., Mitouassiwou, A., Croxatto, A., Opota, O., Prod'hom, G., Henchoz, S., Schoepfer, A., Cavassini, M., Galpérine, T. |
| Jazyk: |
francouzština |
| Rok vydání: |
2021 |
| Předmět: |
|
| Zdroj: |
Revue medicale suisse, vol. 17, no. 734, pp. 726-731 |
| Popis: |
In clinical practice, fecal microbiota transplantation (FMT) has been established as an unparalleled therapy to date for multiple recurrent Clostridioides difficile infections (CDI). The implementation of the FMT in practice requires a significant investment to meet legal, security and financial requirements. Research on the microbiota is booming and multiple investigations on FMT in indications other than CDI are ongoing. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
